Shuji Momose

机构：Social Insurance Saitama Chuo Hospital, Saitama Medical University · ORCID：0000-0003-3986-1409

发表论文 70 篇 · 总被引 940 次 · h-index 18

代表论文

• ARID2 is a pomalidomide-dependent CRL4CRBN substrate in multiple myeloma cells (2020 · Nature Chemical Biology · 被引 100)
• Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (2023 · Leukemia · 被引 64)
• Immunohistochemical staining patterns of p53 predict the mutational status of TP53 in oral epithelial dysplasia (2021 · Modern Pathology · 被引 31)
• Distribution and clinical impact of molecular subtypes with dark zone signature of DLBCL in a Japanese real-world study (2023 · Blood Advances · 被引 27)
• Cancer Antigen 125 Expression Enhances the Gemcitabine/Cisplatin-Resistant Tumor Microenvironment in Bladder Cancer (2022 · American Journal Of Pathology · 被引 20)
• Possible reversibility between epithelioid and sarcomatoid types of mesothelioma is independent of ERC/mesothelin expression (2020 · Respiratory Research · 被引 17)